{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/ATX.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ATX.AU\",,,,,undefined,":{"symbol":"ATX.AU","market":"AU","secType":"STK","nameCN":"AMPLIA THERAPEUTICS LTD","latestPrice":0.145,"timestamp":1788223372031,"preClose":0.135,"halted":0,"volume":1851,"delay":0,"changeRate":0.07407407407407393,"nameEN":"AMPLIA THERAPEUTICS LTD","floatShares":351321835,"shares":513071629,"eps":-0.0164,"marketStatus":"Trading","change":0.01,"latestTime":"09-01 10:44:58 AEST","open":0.145,"high":0.145,"low":0.145,"amount":268,"amplitude":0,"askPrice":0.145,"askSize":290636,"bidPrice":0.135,"bidSize":378473,"shortable":3,"etf":0,"ttmEps":-0.0164,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788242400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.135,"openAndCloseTimeList":[[1788220800000,1788242400000]],"volumeRatio":0.008513,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ATX.AU","preClose":0.145,"auctionPrice":0.135,"auctionVolume":139814,"auction":3,"marketStatus":"盘后竞价","timestamp":1788156602130}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ATX.AU\",,,,,undefined,":{"symbol":"ATX.AU","floatShares":351321835,"roa":"-16.29%","roe":"-25.48%","lyrEps":-0.0164,"volumeRatio":0.008513,"shares":513071629,"dividePrice":0,"high":0.145,"amplitude":0,"preClose":0.135,"low":0.145,"week52Low":0.1,"pbRate":"1.88","psRate":"15.53","week52High":0.275,"institutionHeld":0,"latestPrice":0.145,"committee":0.131275,"eps":-0.0164,"divideRate":0,"volume":1851,"delay":0,"ttmEps":-0.0164,"open":0.145,"prevYearClose":0.15,"prevWeekClose":0.145,"prevMonthClose":0.135,"prevQuarterClose":0.145,"fiveDayClose":0.145,"twentyDayClose":0.155,"sixtyDayClose":0.115,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-04-18","symbol":"ATX.AU","defaultRemindTime":1713398400000,"type":"split","dateTimestamp":1713362400000,"forFactor":971896,"toFactor":1000000,"ratio":0.971896}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATX.AU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612460440","title":"Amplia Therapeutics Ltd-Amplia Emergence 2026 Conference Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2612460440","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612460440?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:13","pubTimestamp":1771362815,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nTUE13F13T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","ATX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610195873","title":"Amplia Therapeutics Announces Opening of US Sites for Amplicity Pancreatic Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2610195873","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610195873?lang=en_us&edition=fundamental","pubTime":"2026-02-11 21:45","pubTimestamp":1770817500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nTUA9G2LJZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610260366","title":"Amplia Therapeutics Opens Two Sites for Pancreatic Cancer Trial Enrollment; Shares Rise 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610260366","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610260366?lang=en_us&edition=fundamental","pubTime":"2026-02-11 09:02","pubTimestamp":1770771722,"startTime":"0","endTime":"0","summary":"Amplia Therapeutics  said it opened two sites in the US, which will shortly start recruitment activities for its Amplicity trial, according to a Wednesday filing with the Australian bourse.The trial will evaluate the company's lead drug, narmafotinib, in advanced pancreatic cancer patients, the filing said.An additional three sites in the US will be initiated in the near future as recruitment continues, the filing added.Shares of the company rose past 4% in recent Wednesday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","ATX.AU","BK4539","BK4139","BK4007","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":43,"code":"91000000","status":"200"}]}}